SCHEMBL7364362

SCHEMBL7364362

O=C(CCCCCCC(=O)C(F)(F)F)NCc1ccc(F)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.71
HPGD P15428 3/20 0.64
HTT P42858 1/20 0.59
HDAC3 O15379 3/20 0.57
HDAC1 Q13547 3/20 0.57
HDAC2 Q92769 3/20 0.57
HDAC8 Q9BY41 3/20 0.57
HDAC10 Q969S8 2/20 0.57
HDAC11 Q96DB2 2/20 0.57
HDAC6 Q9UBN7 2/20 0.57
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
POLB P06746 2/20 0.52
NCOR1 O75376 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
ALDH1A1 P00352 1/20 0.50
RAB9A P51151 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7371613 0.87 HDAC3 (0.56) LMNAHPGDHDAC3HDAC1HDAC2
SCHEMBL7368390 0.87 HDAC3 (0.56) LMNAHPGDHDAC3HDAC1HDAC2
SCHEMBL7368984 0.87 MEN1 (0.76) LMNAHDAC3HDAC1HDAC2HDAC8
SCHEMBL7371165 0.83 CNR1 (0.62) HDAC3HDAC1HDAC2HDAC8HDAC10
SCHEMBL7364507 0.83 HDAC1 (0.60) LMNAHPGDHTTHDAC3HDAC1
SCHEMBL7372287 0.83 MEN1 (0.54) LMNAHDAC3HDAC1HDAC2HDAC8
SCHEMBL28801164 0.83 HTT (0.79) LMNAHPGDHTTHDAC3HDAC1
SCHEMBL15678793 0.82 LMNA (0.76) LMNAHPGDHTTHDAC3HDAC1
SCHEMBL12215274 0.82 HPGD (0.88) LMNAHPGDHTTALDH1A1
SCHEMBL27892109 0.81 HTT (0.81) LMNAHPGDHTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US claimed
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
US-20020103192-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-08-01 US disclosed
WO-2002046129-A2 INHIBITORS OF HISTONE DEACETYLASE ABBOTT LABORATORIES (US) 2002-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103192-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC4 LMNA 1705/4885HPGD 851/4885HTT 1293/4885
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 LMNA 1033/4885HPGD 339/4885HTT 316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.